On March 2, 2026, Pierre Fabre Pharmaceuticals, Inc., submitted a request to the U.S. Food and Drug Administration (FDA) for a Type A meeting on the biologic license application for tabelecleucel, an ...

Kalshi partnership brings AP live vote counts and race calls to prediction market users during 2026 primaries.

A nursing home found to have erred in 99 of 100 reimbursement submissions during the pandemic is fighting back against those ...

In a 48-hour whirlwind, President Trump ordered every federal agency to ditch Anthropic's Claude chatbot, with Defense ...

Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer ...

To be heard by General Law Committee on Wednesday, as State Sen. James Maroney (pictured) focuses fight on algorithmic discrimination.

Slop is killing the résumé. Job hunters are scrambling for new ways to stand out ...

All eyes are on Nvidia's fourth quarter results, due after the closing bell on Wednesday, as AI concerns continue to grip markets.

“It’s been unbelievable,” said Karen Feridun, co-founder of Better Path Coalition, a nonprofit that advocates for clean ...

"Murray N. Rothbard is a scholar of unique, indeed monumental achievements: the founder of the first fully-integrated science of liberty." ...

MONTRÉAL, Feb. 27, 2026 /CNW/ - Imaflex Inc. ("Imaflex" or the "Corporation") (TSXV: IFX) announced today the completion of the previously announced plan of arrangement ...